TSZAF Monomer Combination Inhibits the Progression of Ovarian Cancer Via Regulating the AKT/FOXO3A-mediated Glycolysis Pathway
TSZAF mc inhibits ovarian cancer progression by regulating the AKT/ FOXO3A-mediated glycolysis pathway, which may represent one of the mechanisms underlying the clinical efficacy of TSZAF in ovarian cancer treatment.
Authors
- Jianhui Tian (ORCID: https://orcid.org/0000-0003-4509-6336)
- ZuJun Que
- Yu Pan (ORCID: https://orcid.org/0000-0001-9322-7818)
- Jiayi Liu (ORCID: https://orcid.org/0000-0003-1819-2998)
- Bin Luo (ORCID: https://orcid.org/0000-0001-5948-5055)
- Yue Wu (ORCID: https://orcid.org/0000-0002-9073-5988)
- Jialiang Yao
- Ziqi Chen
- Long Zhang
- Xinyi Lu
Institutions
- Shanghai Mental Health Center (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Shanghai Traditional Chinese Medicine Hospital (CN)
Publication Details
- Journal
- Biological Procedures Online
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1186/s12575-025-00323-z
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00